164 related articles for article (PubMed ID: 21656113)
1. [Adjuvant systemic treatment of melanoma].
Kähler KC; Egberts F; Hauschild A; Mohr P
Hautarzt; 2011 Jun; 62(6):414, 416-22. PubMed ID: 21656113
[TBL] [Abstract][Full Text] [Related]
2. [Current aspects of adjuvant therapy of malignant melanoma].
Kähler KC; Egberts F; Hauschild A
Hautarzt; 2010 Jun; 61(6):523-31; quiz 532-3. PubMed ID: 20512304
[TBL] [Abstract][Full Text] [Related]
3. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
Kirkwood JM; Moschos S; Wang W
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054
[TBL] [Abstract][Full Text] [Related]
4. New drugs in melanoma: it's a whole new world.
Eggermont AM; Robert C
Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for melanoma.
Sondak VK
Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
[TBL] [Abstract][Full Text] [Related]
7. Noninterferon-based adjuvant therapy for high-risk melanoma.
Spitler LE
Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
[TBL] [Abstract][Full Text] [Related]
10. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
11. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
[TBL] [Abstract][Full Text] [Related]
12. Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcome.
Bouwhuis MG; Collette S; Suciu S; de Groot ER; Kruit WH; Ten Hagen TL; Aarden LA; Eggermont AM; Swaak AJ;
Melanoma Res; 2011 Aug; 21(4):344-51. PubMed ID: 21546857
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy of melanoma.
Shah GD; Chapman PB
Cancer J; 2007; 13(3):217-22. PubMed ID: 17620773
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis.
Pirard D; Heenen M; Melot C; Vereecken P
Dermatology; 2004; 208(1):43-8. PubMed ID: 14730236
[TBL] [Abstract][Full Text] [Related]
15. The systemic treatment of advanced cutaneous melanoma.
Logan TF
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
[No Abstract] [Full Text] [Related]
16. Adjuvant therapy in melanoma.
Mohr P; Weichenthal M; Hauschild A
Onkologie; 2003 Jun; 26(3):227-33. PubMed ID: 12845206
[TBL] [Abstract][Full Text] [Related]
17. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
Hauschild A; Lischner S; Christophers E
Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
[TBL] [Abstract][Full Text] [Related]
18. Current and planned multicenter trials for patients with primary or metastatic melanoma.
Sondak VK; Han D; Deneve J; Kudchadkar R
J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapies and melanoma].
Routier É; Robert C; Mateus C
Bull Cancer; 2014 Dec; 101 Suppl 2():S13-24. PubMed ID: 25776763
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
